Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dietlein

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Nuklearmedizin. Nuclear Medicine|August 12, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?C Kobe, I Weber, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?C Kobe, W Eschner, F Sudbrock, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for radioiodine test (Version 3)]M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 1998
[Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy]M Dietlein, C J Troche, D Moka, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 1, 1993
[X-ray studies of the peripheral joints: a comparison of digital luminescence radiography (DLR) and film-screen systems]B Krug, R Fischbach, S Herrmann, et al.
Nuklearmedizin. Nuclear Medicine|August 26, 2003
[PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer]W A Weber, M Dietlein, D Hellwig, et al.
Nuklearmedizin. Nuclear Medicine|June 13, 2003
[Procedure guideline for radioiodine test (version 2)]M Dietlein, J Dressler, W Eschner, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1997
[Polyneuropathies in monoclonal gammopathy of undetermined significance: initial manifestation of a lymphoma]C Drees, M Grond, B Szelies, et al.
European Journal of Nuclear Medicine|December 6, 2000
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT resultsM Dietlein, K Weber, A Gandjour, et al.
BMC Musculoskeletal Disorders|March 4, 2006
The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: results from a prospective, blinded studyK-St Delank, M Schmidt, J W-P Michael, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Nuklearmedizin. Nuclear Medicine|August 12, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?C Kobe, I Weber, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?C Kobe, W Eschner, F Sudbrock, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for radioiodine test (Version 3)]M Dietlein, J Dressler, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 1998
[Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy]M Dietlein, C J Troche, D Moka, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 1, 1993
[X-ray studies of the peripheral joints: a comparison of digital luminescence radiography (DLR) and film-screen systems]B Krug, R Fischbach, S Herrmann, et al.
Nuklearmedizin. Nuclear Medicine|August 26, 2003
[PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer]W A Weber, M Dietlein, D Hellwig, et al.
Nuklearmedizin. Nuclear Medicine|June 13, 2003
[Procedure guideline for radioiodine test (version 2)]M Dietlein, J Dressler, W Eschner, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1997
[Polyneuropathies in monoclonal gammopathy of undetermined significance: initial manifestation of a lymphoma]C Drees, M Grond, B Szelies, et al.
European Journal of Nuclear Medicine|December 6, 2000
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT resultsM Dietlein, K Weber, A Gandjour, et al.
BMC Musculoskeletal Disorders|March 4, 2006
The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: results from a prospective, blinded studyK-St Delank, M Schmidt, J W-P Michael, et al.
Pageof 13